| Application number | Title of the application | Filing Date | Status |
|---|
| 09/339552 | GENE THERAPY FOR EFFECTOR CELL REGULATION | Jun 23, 1999 | Abandoned |
Array
(
[id] => 4357125
[patent_doc_number] => 06291740
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-09-18
[patent_title] => 'Transgenic animals'
[patent_app_type] => 1
[patent_app_number] => 9/329749
[patent_app_country] => US
[patent_app_date] => 1999-06-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 29012
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 199
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/291/06291740.pdf
[firstpage_image] =>[orig_patent_app_number] => 329749
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/329749 | Transgenic animals | Jun 9, 1999 | Issued |
Array
(
[id] => 1393180
[patent_doc_number] => 06548737
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-04-15
[patent_title] => 'Transgenic mice deficient in natural killer cells'
[patent_app_type] => B1
[patent_app_number] => 09/312454
[patent_app_country] => US
[patent_app_date] => 1999-05-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 16
[patent_no_of_words] => 13957
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 13
[patent_words_short_claim] => 80
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/548/06548737.pdf
[firstpage_image] =>[orig_patent_app_number] => 09312454
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/312454 | Transgenic mice deficient in natural killer cells | May 13, 1999 | Issued |
Array
(
[id] => 1536731
[patent_doc_number] => 06337392
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-01-08
[patent_title] => 'Lens transcriptional control elements and methods of use thereof'
[patent_app_type] => B1
[patent_app_number] => 09/306042
[patent_app_country] => US
[patent_app_date] => 1999-05-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 12256
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 74
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/337/06337392.pdf
[firstpage_image] =>[orig_patent_app_number] => 09306042
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/306042 | Lens transcriptional control elements and methods of use thereof | May 5, 1999 | Issued |
Array
(
[id] => 1587320
[patent_doc_number] => 06359194
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-03-19
[patent_title] => 'Compositions and methods for the treatment and diagnosis of cardiovascular disease'
[patent_app_type] => B1
[patent_app_number] => 09/288292
[patent_app_country] => US
[patent_app_date] => 1999-04-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 26
[patent_figures_cnt] => 28
[patent_no_of_words] => 57244
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 42
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/359/06359194.pdf
[firstpage_image] =>[orig_patent_app_number] => 09288292
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/288292 | Compositions and methods for the treatment and diagnosis of cardiovascular disease | Apr 7, 1999 | Issued |
Array
(
[id] => 1238471
[patent_doc_number] => 06685911
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2004-02-03
[patent_title] => 'Sensitization process for antigen-presenting cells and means for implementing the process'
[patent_app_type] => B1
[patent_app_number] => 09/267370
[patent_app_country] => US
[patent_app_date] => 1999-03-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 17
[patent_no_of_words] => 17966
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 113
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/685/06685911.pdf
[firstpage_image] =>[orig_patent_app_number] => 09267370
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/267370 | Sensitization process for antigen-presenting cells and means for implementing the process | Mar 14, 1999 | Issued |
| 09/268135 | INTERFERON ALPHA PLASMIDS AND DELIVERY SYSTEMS, AND METHODS OF MAKING AND USING THE SAME | Mar 11, 1999 | Abandoned |
| 09/254410 | MODEL FOR THE PAPILLOMA VIRUS INFECTION IN VIVO, CONSISTING OF THE SCID-BO MOUSE | Mar 4, 1999 | Abandoned |
| 09/257417 | NUCLEIC ACID MOLECULES ASSOCIATED WITH MELANOMA AND THYROID TUMORS | Feb 24, 1999 | Abandoned |
| 09/242296 | DELIVERY OF TOLEROGENIC ANTIGENS VIA EDIBLE PLANTS OR PLANT-DERIVED PRODUCTS | Feb 15, 1999 | Abandoned |
Array
(
[id] => 1490010
[patent_doc_number] => 06417002
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-07-09
[patent_title] => 'Method for maintenance and selection of episomes'
[patent_app_type] => B1
[patent_app_number] => 09/249585
[patent_app_country] => US
[patent_app_date] => 1999-02-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 9
[patent_no_of_words] => 13411
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 105
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/417/06417002.pdf
[firstpage_image] =>[orig_patent_app_number] => 09249585
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/249585 | Method for maintenance and selection of episomes | Feb 10, 1999 | Issued |
Array
(
[id] => 1528741
[patent_doc_number] => 06479654
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-11-12
[patent_title] => 'Forms of the angiogenic factor vascular endothelial cell growth factor: VEGF'
[patent_app_type] => B1
[patent_app_number] => 09/244583
[patent_app_country] => US
[patent_app_date] => 1999-02-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 23393
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/479/06479654.pdf
[firstpage_image] =>[orig_patent_app_number] => 09244583
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/244583 | Forms of the angiogenic factor vascular endothelial cell growth factor: VEGF | Feb 3, 1999 | Issued |
| 09/230600 | NOVEL LIPOLYTIC ENZYMES | Jan 26, 1999 | Abandoned |
Array
(
[id] => 1504709
[patent_doc_number] => 06465617
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-10-15
[patent_title] => 'Identification and characterization of a gene which protects cells from programmed cell death and uses therefor'
[patent_app_type] => B1
[patent_app_number] => 09/233527
[patent_app_country] => US
[patent_app_date] => 1999-01-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 22
[patent_no_of_words] => 23274
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 27
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/465/06465617.pdf
[firstpage_image] =>[orig_patent_app_number] => 09233527
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/233527 | Identification and characterization of a gene which protects cells from programmed cell death and uses therefor | Jan 19, 1999 | Issued |
| 09/219698 | TARGETED GENE TRANSFER USING G PROTEIN COUPLED RECEPTORS | Dec 22, 1998 | Abandoned |
Array
(
[id] => 1562348
[patent_doc_number] => 06362326
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-03-26
[patent_title] => '11 cby genomic sequence'
[patent_app_type] => B1
[patent_app_number] => 09/218467
[patent_app_country] => US
[patent_app_date] => 1998-12-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 1
[patent_no_of_words] => 12836
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/362/06362326.pdf
[firstpage_image] =>[orig_patent_app_number] => 09218467
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/218467 | 11 cby genomic sequence | Dec 21, 1998 | Issued |
Array
(
[id] => 1546743
[patent_doc_number] => 06444870
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-09-03
[patent_title] => 'Methods for assessing the role of calcineurin immunosuppression and neurotoxicity'
[patent_app_type] => B1
[patent_app_number] => 09/212868
[patent_app_country] => US
[patent_app_date] => 1998-12-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 31811
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 56
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/444/06444870.pdf
[firstpage_image] =>[orig_patent_app_number] => 09212868
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/212868 | Methods for assessing the role of calcineurin immunosuppression and neurotoxicity | Dec 15, 1998 | Issued |
| 09/193834 | METHODS OF CREATING CONSTRUCTS USEFUL FOR INTRODUCING SEQUENCES INTO EMBRYONIC STEM CELLS | Nov 16, 1998 | Abandoned |
| 09/171802 | GENE EXPRESSION IN MONOCYTES AND MACROPHAGES | Oct 25, 1998 | Abandoned |
Array
(
[id] => 1277166
[patent_doc_number] => 06641526
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-11-04
[patent_title] => 'Development of normal offspring from oocytes injected with freeze-dried spermatozoa'
[patent_app_type] => B1
[patent_app_number] => 09/177391
[patent_app_country] => US
[patent_app_date] => 1998-10-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 8851
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 72
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/641/06641526.pdf
[firstpage_image] =>[orig_patent_app_number] => 09177391
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/177391 | Development of normal offspring from oocytes injected with freeze-dried spermatozoa | Oct 22, 1998 | Issued |
